Provided by Tiger Trade Technology Pte. Ltd.

Biogen

221.07
+0.30000.14%
Post-market: 219.93-1.1400-0.52%17:56 EDT
Volume:647.17K
Turnover:142.86M
Market Cap:32.64B
PE:39.27
High:222.00
Open:219.34
Low:218.69
Close:220.77
52wk High:222.85
52wk Low:131.52
Shares:147.64M
Float Shares:147.31M
Volume Ratio:0.91
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.73
PE(LYR):25.15

Loading ...

Biogen CFO Robin Kramer to Join Wells Fargo Healthcare Conference Fireside Chat

Reuters
·
Yesterday

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Biogen is Maintained at Outperform by RBC Capital

Dow Jones
·
Aug 25

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live
·
Aug 25

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

TIPRANKS
·
Aug 25

RBC Capital Adjusts Price Target on Biogen to $260 From $240

MT Newswires Live
·
Aug 25

Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

MT Newswires Live
·
Aug 24

Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.

TIPRANKS
·
Aug 24

Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease

THOMSON REUTERS
·
Aug 24

How Investors Are Reacting To Biogen (BIIB) Raising EPS Guidance On Late-Stage Drug Trial Milestones

Simply Wall St.
·
Aug 23

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial

TIPRANKS
·
Aug 22

Biogen Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 11 of 19 Names at New Peaks

Reuters
·
Aug 20

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 19

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

TIPRANKS
·
Aug 14

Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300

MT Newswires Live
·
Aug 13

Barclays Keeps Their Hold Rating on Biogen (BIIB)

TIPRANKS
·
Aug 13

Biogen Files Form 3 Initial Beneficial Ownership Statement for Chief Legal Officer Michael Parini

Reuters
·
Aug 13